Diego A. Díaz-García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology and Medical Oncologist at Angeles del Carmen Hospital, shared a paper on X by Taiwo Adesoye et al. published in Clinical Cancer Research:
“Targeting HER2 across cancer subtypes.
HER2 targeting is moving beyond breast and gastric cancer. ADCs, TKIs, and bispecific antibodies show clinically meaningful activity across multiple HER2-expressing and HER2-mutant solid tumors, including lung and colorectal cancer.
Key challenges include heterogeneity, resistance, and biomarker selection.”
Title: Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach
Authors: Taiwo Adesoye, Ecaterina Dumbrava, Kanwal Raghav, Aysegul Sahin, Hui Chen, Sunyoung Lee, Milind Javle, Shubham Pant, Omar Alhalabi, Xiuning Le, Vicente Valero, Paula Pohlmann, Funda Meric-Bernstam
Read the Full Article in Clinical Cancer Research.
More posts about Diego A. Díaz-García.
